In 2015, the paper award committee received over 50 eligible articles and will select up to five papers of outstanding quality to be awarded a prize, based on the following criteria:
- scientific originality;
- scientific quality;
- clarity and quality of writing; and
- EU relevance.
This year's ceremony was held on 23 September (Lisbon) in the margins of the First European conference on addictive behaviours and dependencies, which provided a unique networking opportunity for researchers, practitioners and policy experts across countries and disciplines to discuss latest findings on the prevention, treatment and control of addiction.
For more information on the conference visit www.lisbonaddictions.eu
Links to abstracts and full text (where available) of the winning papers are available online.
Nomination and eligibility
The award showcases innovative research in the drugs field. Each year, the EMCDDA asks its partners to nominate papers focusing on illicit drugs or new psychoactive substances. The articles will have been published in the previous year in a peer-reviewed scientific journal, with the primary author being of European nationality or based in a European country.
- Each nominated paper should be classified according to the following research fields:
- Basic biological, neurobiological and behavioural research (including aetiological and addictive behaviour research);
- Population based research and clinical epidemiology (including site surveys, ethnographic studies and acute toxicity studies);
- Demand reduction (including prevention, treatment, harm reduction, reintegration and clinical treatment research);
- Supply, supply reduction and crime;
- Drug policy (including laws, economic issues and strategies);
- Other topics.
The scientific award was inaugurated in 2011 to showcase innovative research in drugs field.